Coldstream Capital Management Inc Zai Lab LTD Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Zai Lab LTD stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,305 shares of ZLAB stock, worth $40,389. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,305Holding current value
$40,389% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ZLAB
# of Institutions
168Shares Held
55MCall Options Held
68.2KPut Options Held
377K-
Capital World Investors Los Angeles, CA6.01MShares$186 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$118 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.65MShares$113 Million0.03% of portfolio
-
Clearbridge Investments, LLC New York, NY3.28MShares$102 Million0.11% of portfolio
-
Morgan Stanley New York, NY3.17MShares$98 Million0.01% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.03B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...